Please see here for slides of the AGM.
Please see here for minutes of the AGM.
ELECTION RESULTS We thank the following Members of the Board stepping down for their dedication and service to the continued growth and relevance of ESGCT: Adrian Thrasher (University College London) The following Members of the Board stood for re-election and were re-elected: Vincenzo Cerullo (University of Helsinki) We welcome the following members newly to the Board and look forward to their contributions: Claire Booth (UCL Institute of Child Health) ===========================
2019 AGM - invitation As per §14 of the Bylaws of our society, we hereby invite you to our 2019 Annual General Meeting (AGM). The AGM will take place on Thursday 24 October 2019 at the end of the Presidential Symposium. The Presidential Symposium is scheduled from 11:00 to 13:15. The following agenda is proposed:
Please send any additions to the agenda in writing with a justification no later than Monday 14 October 2019. Please note you can view the ESGCT Bylaws here. Please do not forget to sign the attendance sheet during the AGM. The minutes will be written by Gaelle Jamar. You can access your AGM materials in your personal member area here. With kind regards, Hildegard Büning ESGCT President
Non-viral genetic therapy strategies for the treatment of ataxia telangiectasia
James Grey received the ESGCT-sponsored prize for best poster presentation at the British Society for Gene and Cell Therapy (BSGCT) Annual Conference, which took place from 19-21 June 2019. Read about his winning presentation here!
Gene therapy for thrombotic thrombocytopaenic purpura
Robyn Bell received the ESGCT-sponsored prize for best oral presentation at the British Society for Gene and Cell Therapy (BSGCT) Annual Conference, which took place from 19-21 June 2019. Read about her winning presentation here!
CRISPR-Cas9 genome editing - molecular scissors a bit too sharp?
Grégoire Cullot received the ESGCT-sponsored prize for best oral presentation at the Société Française de Thérapie Cellulaire et Génique (SFTCG) Thematic Day on Viral Vectors, which took place on 17 May 2019 in Paris. Read about his winning presentation here!
Dgkk as a new therapeutic target in the Fmr1-KO murine model of Fragile X
Karima Habbas received the ESGCT-sponsored prize for best poster at the Société Française de Thérapie Cellulaire et Génique (SFTCG) Thematic Day on Viral Vectors, which took place on 17 May 2019 in Paris. Read about her winning presentation here!